v3.26.1
Segment Information
 6 Months Ended
Jun. 30, 2026
Segment Information [Abstract]  
Segment Information

Note 10 – Segment Information

 

The Company conducts its business as a single operating and reportable segment based on its organizational and management structure and the manner in which the Chief Operating Decision Maker (“CODM”) reviews financial information to allocate resources and assess performance, consistent with the Company’s segment reporting policy described in Note 2. The accounting policies of the Company’s single operating segment are the same as those described in Note 2. The key measure of segment profitability used by the CODM to allocate resources and assess performance is net income (loss), as reported on the unaudited condensed consolidated statements of operations. The following table presents the significant expense categories of the Company’s single operating segment for the periods presented.

 

    For the Three Months Ended
June 30,		    

For the Six Months

Ended June 30,

  
    2026     2025     2026     2025  
    (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)  
Operating expenses and other expenses:                        
Clinical trial related service fee to related party (Note 5)   $ 1,375,000     $ 4,625,000     $ 2,750,000     $ 6,000,000  
Consulting fee     15,000       25,000       30,000       50,000  
Stock-based compensation (Note 8)     145,298       159,098       292,012       318,193  
Salary expense     131,272       131,096       260,036       260,807  
Professional fee     289,932       475,437       688,065       760,527  
Insurance expense     81,850       83,636       161,189       164,693  
Other general and administrative fee     45,895       44,761       86,382       94,106  
Change in fair value of derivative liabilities     222,092       -       330,719       -  
Loss before income tax     2,306,339       5,544,028       4,598,403       7,648,326  
                                 
Income tax expense     -       850       -       863  
Net loss   $ 2,306,339     $ 5,544,878     $ 4,598,403     $ 7,649,189